Insmed Incorporated
Stock Forecast, Prediction & Price Target
Insmed Incorporated Financial Estimates
Insmed Incorporated Revenue Estimates
Insmed Incorporated EBITDA Estimates
Insmed Incorporated Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $188.46M N/A | $245.35M 30.19% | $305.20M 24.39% | Avg: $518.79M Low: $518.79M High: $518.79M avg. 69.98% | Avg: $903.93M Low: $903.93M High: $903.93M avg. 74.23% | Avg: $1.49B Low: $1.49B High: $1.49B avg. 65.29% | Avg: $2.12B Low: $2.12B High: $2.12B avg. 42.42% |
Net Income
% change YoY
| $-434.65M N/A | $-481.53M -10.78% | $-749.56M -55.66% | Avg: $-554.38M Low: $-554.38M High: $-554.38M avg. 26.03% | Avg: $-310.62M Low: $-310.62M High: $-310.62M avg. 43.96% | Avg: $30.71M Low: $30.71M High: $30.71M avg. 109.88% | Avg: $380.57M Low: $380.57M High: $380.57M avg. 1138.85% |
EBITDA
% change YoY
| $-373.37M N/A | $-458.20M -22.72% | $-654.73M -42.89% | Avg: $-518.79M Low: $-518.79M High: $-518.79M avg. 20.76% | Avg: $-903.93M Low: $-903.93M High: $-903.93M avg. -74.23% | Avg: $-1.49B Low: $-1.49B High: $-1.49B avg. -65.29% | Avg: $-2.12B Low: $-2.12B High: $-2.12B avg. -42.42% |
EPS
% change YoY
| -$3.88 N/A | -$3.91 -0.77% | -$5.34 -36.57% | Avg: -$3.95 Low: -$3.95 High: -$3.95 avg. 26.07% | Avg: -$2.21 Low: -$2.21 High: -$2.21 avg. 43.96% | Avg: $0.22 Low: $0.22 High: $0.22 avg. 109.88% | Avg: $2.71 Low: $2.71 High: $2.71 avg. 1138.85% |
Operating Expenses
% change YoY
| $512.06M N/A | $668.35M 30.52% | $949.26M 42.02% | Avg: $647.27M Low: $647.27M High: $647.27M avg. -31.81% | Avg: $1.12B Low: $1.12B High: $1.12B avg. 74.23% | Avg: $1.86B Low: $1.86B High: $1.86B avg. 65.29% | Avg: $2.65B Low: $2.65B High: $2.65B avg. 42.42% |
FAQ
What is Insmed Incorporated stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 329.68% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -554.38M, average is -554.38M and high is -554.38M.
What is Insmed Incorporated stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 62.98% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $518.79M, average is $518.79M and high is $518.79M.
What is Insmed Incorporated stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 329.69% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$3.95, average is -$3.95 and high is $-3.94.